LabGenomics (Korea) Today

084650 Stock  KRW 2,630  75.00  2.77%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 10

 
High
 
Low
Low
LabGenomics is trading at 2630.00 as of the 22nd of November 2024, a 2.77 percent decrease since the beginning of the trading day. The stock's open price was 2705.0. LabGenomics has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for LabGenomics Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of September 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

LabGenomics Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. LabGenomics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding LabGenomics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationHealthcare Providers & Services, Healthcare (View all Sectors)
LabGenomics Co (084650) is traded on KOSDAQ in Korea and employs 233 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LabGenomics's market, we take the total number of its shares issued and multiply it by LabGenomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. LabGenomics operates under Healthcare sector and is part of Healthcare Providers & Services industry. The entity has 9.08 M outstanding shares. LabGenomics Co has accumulated about 70.53 B in cash with 66.08 B of positive cash flow from operations.
Check LabGenomics Probability Of Bankruptcy
Ownership Allocation
The market capitalization of LabGenomics Co is W61 Billion. LabGenomics Co secures 12.68 % of its outstanding shares held by insiders and 1.09 % owned by institutional investors. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check LabGenomics Ownership Details

LabGenomics Risk Profiles

Although LabGenomics' alpha and beta are two of the key measurements used to evaluate LabGenomics' performance over the market, the standard measures of volatility play an important role as well.

LabGenomics Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in LabGenomics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Dashboard Now

   

Portfolio Dashboard

Portfolio dashboard that provides centralized access to all your investments
All  Next Launch Module

Other Information on Investing in LabGenomics Stock

LabGenomics financial ratios help investors to determine whether LabGenomics Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LabGenomics with respect to the benefits of owning LabGenomics security.